HCC: Updates from ILCA and ESMO 2022

December 06, 2023 00:30:22
HCC: Updates from ILCA and ESMO 2022
COR2ED - Oncology Medical Conversation
HCC: Updates from ILCA and ESMO 2022

Dec 06 2023 | 00:30:22

/

Show Notes

In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of new HCC Phase 3 clinical trials data presented and discussed at the ILCA and ESMO congresses. They discuss Immuno-oncology agents and their place in the upcoming updated guidance such as the proposed new ILCA Systemic Therapies Guidance algorithm. They also discuss new treatment options in first line for advanced HCC presented at ESMO including the three late breaking abstracts LEAP-002, RATIONALE-301 and tislelizumab monotherapy trials. The latter two studying first-line treatment with an anti-PD1 antibody with or without a kinase inhibitor in patients with advanced hepatocellular carcinoma. The experts evaluate and provide their insights into how to integrate these new treatments for HCC in the clinical practice.

Other Episodes

Episode

January 20, 2025 00:27:12
Episode Cover

Intermediate HCC – The evolving role of IO

Intermediate HCC – The evolving role of IO  In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology...

Listen

Episode

December 06, 2023 00:25:18
Episode Cover

Upper GI cancer Highlights from ASCO GI 2023 - Part 1

This episode, covers the highlights on gastroesophageal, gastric and gastroesophageal junction (GEJ) cancer from ASCO GI 2023.  Dr Nataliya Uboha (University of Wisconsin, USA)...

Listen

Episode

September 11, 2024 00:29:55
Episode Cover

Neuroendocrine tumours (NETs) – Shared decision-making. Part 1: Patient journey

In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...

Listen